Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|July 28, 2007
[Severe rigid kyphotic scoliosis treated with posterior spinal osteotomy]Chun De Li, Hong Li, Xian Yi Liu
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|April 26, 2006
[Influence factors of adjacent segment degeneration after instrumented lumbar fusion]Chun-de Li, Zheng-rong Yu, Xian-yi Liu, et al.
Chinese Journal of Traumatology = Zhonghua Chuang Shang Za Zhi|July 15, 2003
The effect of Shen-Fu on gastrointestinal tract injury and its potential mechanism during cardio-pulmonary bypass in patients undergoing cardiac surgeryZhong-yuan Xia, Li-ying Zhan, Yu-hong He, et al.
Zhonghua Yi Xue Za Zhi|May 10, 2006
[Clinical character and treatment of coexistence of cervical spine disease and lumbar spine degenerative disease]Xian-yi Liu, Chun-de Li, Xiao-dong Yi, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|December 19, 2012
[Analysis of risk factors for delirium in the elderly patients after spinal operation]Hong Li, Chun-de Li, Xiao-dong Yi, et al.
Zhonghua Yi Xue Za Zhi|May 16, 2008
[Surgical treatment of cervical spondylotic amyotrophy]Xian-Yi Liu, Chun-De Li, Xiao-Dong Yi, et al.
World Journal of Orthopedics|January 26, 2016
Surgical treatment of sacral fractures following lumbosacral arthrodesis: Case report and literature reviewYu Wang, Xian-Yi Liu, Chun-De Li, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 4, 2005
Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart diseaseZhong-yuan Xia, Xian-yi Liu, Li-ying Zhan, et al.
European Journal of Histochemistry : EJH|January 22, 2021
Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significancesZhi Chen, Na Cui, Ji-Sen Zhao, et al.
Archives of Biochemistry and Biophysics|April 27, 2025
NFAT2 promotes sorafenib resistance in hepatocellular carcinoma cells by modulating calcium ion signallingJian Wang, Yi Bai, Xian-Yi Liu, et al.
Pageof 2